The primary purpose of the Mouse Models Core Facility is the proficient affordable generation of geneticallymodified mice for both basic and translational cancer research by Moffitt investigators. Advances inexperimental manipulation of the laboratory mouse via gene expression, mutation, or deletion strategieshave propelled major progress in the fields of developmental biology, physiology, and pathology. Transgenicand targeted mice serve as incomparable models of gene function (or dysfunction) in context in vivo andthereby contribute greatly to our understanding of dynamic, complex oncogenic mechanisms. These modelsare also invaluable in studies of the prevention, treatment, and etiology of cancer and other diseases. Forinvestigators, the disadvantages or deterrents to studying these mouse models are the substantial cost, time,equipment, and expertise required for their derivation and examination. The Mouse Models Core also offersluciferase expressing tumor cell lines and bioluminescent imaging with the Xenogen MS workstation forimproved study of traditional xenograft mouse models.The specific objectives of the core are to:- Advise investigators on the overall strategy and design of transgenic and targeting vectors;- Provide relevant plasmid vectors and lambda genomic libraries;- Provide embryonic stem (ES) cells and instruction in their culture, transfection, selection, screening;- Provide pronuclear DMA microinjection services to generate transgenic founder mice;- Provide blastocyst microinjection services to generate germline chimeras from targeted ES cells;- Advise and assist investigators in the genotypic and phenotypic analyses of mice;- Provide cryopreservation and pathogen-free rederivation of genetically engineered mouse models; and- Provide luciferase-tagged tumor cell lines and bioluminescent imaging for xenograft mouse models.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA076292-09
Application #
7516328
Study Section
Subcommittee G - Education (NCI)
Project Start
2007-02-01
Project End
2012-01-31
Budget Start
2007-02-01
Budget End
2008-01-31
Support Year
9
Fiscal Year
2007
Total Cost
$45,996
Indirect Cost
Name
H. Lee Moffitt Cancer Center & Research Institute
Department
Type
DUNS #
139301956
City
Tampa
State
FL
Country
United States
Zip Code
33612
Perales-Puchalt, Alfredo; Perez-Sanz, Jairo; Payne, Kyle K et al. (2018) Frontline Science: Microbiota reconstitution restores intestinal integrity after cisplatin therapy. J Leukoc Biol 103:799-805
Davis, Stacy N; Govindaraju, Swapamthi; Jackson, Brittany et al. (2018) Recruitment Techniques and Strategies in a Community-Based Colorectal Cancer Screening Study of Men and Women of African Ancestry. Nurs Res 67:212-221
Martínez, Úrsula; Brandon, Thomas H; Sutton, Steven K et al. (2018) Associations between the smoking-relatedness of a cancer type, cessation attitudes and beliefs, and future abstinence among recent quitters. Psychooncology 27:2104-2110
Kasting, Monica L; Giuliano, Anna R; Reich, Richard R et al. (2018) Hepatitis C Virus Screening Trends: Serial Cross-Sectional Analysis of the National Health Interview Survey Population, 2013-2015. Cancer Epidemiol Biomarkers Prev 27:503-513
Nelson, Ashley M; Jim, Heather S L; Small, Brent J et al. (2018) Sleep disruption among cancer patients following autologous hematopoietic cell transplantation. Bone Marrow Transplant 53:307-314
Singh, Kshipra; Coburn, Lori A; Asim, Mohammad et al. (2018) Ornithine Decarboxylase in Macrophages Exacerbates Colitis and Promotes Colitis-Associated Colon Carcinogenesis by Impairing M1 Immune Responses. Cancer Res 78:4303-4315
Pidala, Joseph; Beato, Francisca; Kim, Jongphil et al. (2018) In vivo IL-12/IL-23p40 neutralization blocks Th1/Th17 response after allogeneic hematopoietic cell transplantation. Haematologica 103:531-539
Denson, Aaron; Burke, Nancy; Wapinsky, Georgine et al. (2018) Clinical Outcomes of Patients With Gastrointestinal Malignancies Participating in Phase I Clinical Trials. Am J Clin Oncol 41:133-139
Betts, Brian C; Bastian, David; Iamsawat, Supinya et al. (2018) Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation. Proc Natl Acad Sci U S A 115:1582-1587
Hoogland, Aasha I; Lechner, Suzanne C; Gonzalez, Brian D et al. (2018) Efficacy of a Spanish-Language Self-Administered Stress Management Training intervention for Latinas undergoing chemotherapy. Psychooncology 27:1305-1311

Showing the most recent 10 out of 1254 publications